Head to Head Analysis: Harsco (NYSE:HSC) & CRYO-CELL International (NYSE:CCEL) – Redmond Register

Posted: March 24, 2020 at 9:42 am

Harsco (NYSE:HSC) and CRYO-CELL International (OTCMKTS:CCEL) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, analyst recommendations and risk.

Valuation and Earnings

This table compares Harsco and CRYO-CELL Internationals top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Harsco and CRYO-CELL Internationals net margins, return on equity and return on assets.

Risk & Volatility

Harsco has a beta of 2.27, meaning that its share price is 127% more volatile than the S&P 500. Comparatively, CRYO-CELL International has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500.

Insider and Institutional Ownership

92.2% of Harsco shares are owned by institutional investors. Comparatively, 0.3% of CRYO-CELL International shares are owned by institutional investors. 1.8% of Harsco shares are owned by company insiders. Comparatively, 54.0% of CRYO-CELL International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Harsco and CRYO-CELL International, as reported by MarketBeat.

Harsco presently has a consensus target price of $26.67, indicating a potential upside of 325.99%. Given Harscos higher possible upside, analysts clearly believe Harsco is more favorable than CRYO-CELL International.

Summary

Harsco beats CRYO-CELL International on 8 of the 12 factors compared between the two stocks.

Harsco Company Profile

Harsco Corporation provides industrial services and engineered products worldwide. The company operates in three segments: Harsco Metals & Minerals, Harsco Industrial, and Harsco Rail. The Harsco Metals & Minerals segment provides on-site services of material logistics, product quality improvement, and resource recovery for iron, steel, and metals manufacturing; and value added environmental solutions for industrial co-products, as well as produces industrial abrasives and roofing granules. The Harsco Industrial segment manufactures and supplies custom-engineered and manufactured air-cooled heat exchangers for the natural gas, natural gas processing, and petrochemical industries; industrial grating products, such as metal bar grating configurations for industrial flooring, and safety and security applications in the energy, paper, chemical, refining, and processing industries. It also offers heat transfer products, such as boilers and water heaters for commercial and institutional applications; and high-security fencing products. The Harsco Rail segment designs and manufactures safety systems for transportation and industrial applications; and equipment, after-market parts, and services for the maintenance, repair, and construction of railway track. It serves private and government-owned railroads, and urban mass transit systems. Harsco Corporation was founded in 1853 and is headquartered in Camp Hill, Pennsylvania.

CRYO-CELL International Company Profile

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue specimens worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was founded in 1989 and is headquartered in Oldsmar, Florida.

Receive News & Ratings for Harsco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harsco and related companies with MarketBeat.com's FREE daily email newsletter.

Read the original:
Head to Head Analysis: Harsco (NYSE:HSC) & CRYO-CELL International (NYSE:CCEL) - Redmond Register

Related Post